930303-55-2 Usage
Uses
Used in Pharmaceutical Research:
2-Chloro-7,8-dihydro-1,7-naphthyridin-8-one is used as an intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure and reactivity contribute to the development of new drugs and other important molecules.
Used in Agrochemicals:
2-CHLORO-7,8-DIHYDRO-1,7-NAPHTHYRIDIN-8-ONE is also used as an intermediate in the synthesis of agrochemicals, playing a crucial role in the development of new pesticides and other agricultural products.
Used in Organic Synthesis:
2-Chloro-7,8-dihydro-1,7-naphthyridin-8-one serves as a valuable building block in organic synthesis, enabling the creation of a wide range of chemical compounds with various applications.
Used in Medicinal Chemistry Research:
Due to its potential biological activities and unique properties, 2-chloro-7,8-dihydro-1,7-naphthyridin-8-one is an interesting target for further research and development in the field of medicinal chemistry, where it can be explored for its therapeutic potential and other applications.
Check Digit Verification of cas no
The CAS Registry Mumber 930303-55-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,0,3,0 and 3 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 930303-55:
(8*9)+(7*3)+(6*0)+(5*3)+(4*0)+(3*3)+(2*5)+(1*5)=132
132 % 10 = 2
So 930303-55-2 is a valid CAS Registry Number.
930303-55-2Relevant articles and documents
AZA-QUINOLINE COMPOUNDS AND USES THEREOF
-
, (2021/04/02)
Provided aza-quinoline compounds of Formula (I), pharmaceutical compositions comprising such compounds; and the use of such compounds for treating a disease or condition mediated by Enhancer of Zeste Homolog 2 (EZH2), Polycomb Repressive Complex 2 (PRC2), or a combination thereof.
SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE
-
, (2020/12/11)
The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.
Naphthyridin derivatives
-
Page/Page column 30, (2008/06/13)
The present invention relates to heterocyclic derivatives of formula I wherein R1, R2 and R3 are as defined in the description and claims, which compounds are metabotropic glutamate receptor 5 antagonists.
